- Home
- TENX vs IBIO Comparison
TENX vs IBIO Comparison
Compare TENX & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- IBIO
- Stock Information
- Founded
- TENX 1967
- IBIO 2008
- Country
- TENX United States
- IBIO United States
- Employees
- TENX N/A
- IBIO N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- TENX Health Care
- IBIO Health Care
- Exchange
- TENX Nasdaq
- IBIO Nasdaq
- Market Cap
- TENX 21.8M
- IBIO 24.3M
- IPO Year
- TENX N/A
- IBIO N/A
- Fundamental
- Price
- TENX $6.37
- IBIO $2.83
- Analyst Decision
- TENX Strong Buy
- IBIO Strong Buy
- Analyst Count
- TENX 4
- IBIO 3
- Target Price
- TENX $20.67
- IBIO $4.87
- AVG Volume (30 Days)
- TENX 38.7K
- IBIO 132.6K
- Earning Date
- TENX 11-13-2024
- IBIO 02-07-2025
- Dividend Yield
- TENX N/A
- IBIO N/A
- EPS Growth
- TENX N/A
- IBIO N/A
- EPS
- TENX N/A
- IBIO N/A
- Revenue
- TENX N/A
- IBIO $175,000.00
- Revenue This Year
- TENX N/A
- IBIO N/A
- Revenue Next Year
- TENX N/A
- IBIO N/A
- P/E Ratio
- TENX N/A
- IBIO N/A
- Revenue Growth
- TENX N/A
- IBIO 250.00
- 52 Week Low
- TENX $2.77
- IBIO $1.02
- 52 Week High
- TENX $21.46
- IBIO $4.98
- Technical
- Relative Strength Index (RSI)
- TENX 57.59
- IBIO 61.21
- Support Level
- TENX $5.92
- IBIO $2.40
- Resistance Level
- TENX $6.65
- IBIO $2.93
- Average True Range (ATR)
- TENX 0.43
- IBIO 0.19
- MACD
- TENX -0.02
- IBIO 0.04
- Stochastic Oscillator
- TENX 56.21
- IBIO 83.87
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.